Brecon and Quadramed join forces

Leading pharmaceutical outsource provider Brecon Pharmaceuticals Ltd and international regulatory affairs consultancy QuadraMed Ltd, have formed a partnership to offer their customers a comprehensive clinical trials support service.



Following the introduction of the new EU Clinical Trials Directive in May, pharmaceutical companies carrying out clinical trials have had to comply with an increasing and often confusing array of new legislation. By establishing the new specialist partnership, both Brecon's and QuadraMed's customers can now receive a fully comprehensive clinical trials service from a single point of contact.

Brecon's Head of Clinical Services, Dr Sue Miles, believes the partnership with QuadraMed Ltd provides customers with the best in support and advice. She said, "There is an increasing demand from our customers for guidance in the completion and submission of regulatory documentation, translation services or EU legal representation. By establishing this partnership with a specialist regulatory affairs consultancy such as QuadraMed, we can now offer our customers a specialist and comprehensive service." Commenting on the partnership, Mr Chris Brooks, Director at QuadraMed Ltd, said, "We are delighted to be working alongside Brecon Pharmaceuticals as both companies can share and utilise their complementary expertise. On occasion our clients require analytical services, QP or packaging support, and we can now offer these specialist services through Brecon."

29 July 2021

Back to News Articles
Find out more about what's going on at Brecon...